Gabapentinoid prescribing in Veterans Administration emergency departments implementing EQUIPPED

J Am Geriatr Soc. 2024 Apr;72(4):1265-1268. doi: 10.1111/jgs.18759. Epub 2024 Jan 19.

Quratulain Syed^{1

2}, Gerald McGwin^{1

3}, Zachary Burningham^{4

5}, Jessica L Kelleher⁶, Jennie Mather⁶, Susan N Hastings^{7

8}, Melissa B Stevens⁹, Isis Morris⁸, George L Jackson^{8

10

11

12

13}, Camille P Vaughan^{1

2}

¹ Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research, Education, and Clinical Center, Brookhaven, Georgia, USA.
² Department of Medicine, Division of Geriatrics and Gerontology, Emory University, Atlanta, Georgia, USA.
³ Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
⁴ Decision-Enhancement and Analytic Sciences (IDEAS) Centers of Innovation (COIN), Salt Lake City Veterans Affairs Medical Center, Salt Lake City, Utah, USA.
⁵ Department of Internal Medicine, Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
⁶ VA Data Analytics Core (DAC), Atlanta VA Healthcare System, Atlanta, Georgia, USA.
⁷ Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA.
⁸ Department of Medicine, Division of Geriatrics, Duke University, Durham, North Carolina, USA.
⁹ Department of Medicine, Division of General Internal Medicine, Emory University, Atlanta, Georgia, USA.
¹⁰ Department of Population Health Sciences, Duke University, Durham, North Carolina, USA.
¹¹ Department of Medicine, Division of General Internal Medicine, Duke University, Durham, North Carolina, USA.
¹² Department of Family Medicine & Community Health, Duke University, Durham, North Carolina, USA.
¹³ Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

No abstract available

Keywords: gabapentinoids; polypharmacy; potentially inappropriate medications.

MeSH terms